Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Dyax and Eclipse Therapeutics enter licensing agreement

April 18, 2012

Abbott in-licenses Stanford University biomarkers for prostate cancer

April 18, 2012

DFH Pharma and NIH collaborate on development of HIV drugs

April 18, 2012

Conformetrix enters first collaboration agreement

April 17, 2012

Merck & Co. gains worldwide rights to anticancer conjugate

April 17, 2012

Proteros and Eisai launch research collaboration

April 17, 2012

Vanda Pharmaceuticals acquires tachykinin NK1 receptor antagonist

April 17, 2012

Piramal Imaging acquires PET tracers from Bayer

April 16, 2012

AstraZeneca and DNDi enter drug screening collaboration

April 13, 2012

AnGes and BioLeaders enter agreement on oral vaccine for hypertension

April 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.